News Focus
News Focus
icon url

Cre8tivmynd

11/26/19 9:39 AM

#4182 RE: Hezekia #4181

Hezekia, I believe the only person you're upsetting is Miketrav. Apparently, he believes the nonsense that someone can effect share price by posting here. That's his problem, not yours. Truth is, I've stopped reading Mike's posts. I find his hubris tiresome. Whether the "Mad Money" appearance happens..we'll see. I certainly hope it happens. But after 30 years of investing in small-cap clinical stage biotechs, I don't ever make buy/sell decisions based on what I read on a message board. Please keep posting whatever you find. Your contributions are appreciated.
icon url

Fmello

11/26/19 9:41 AM

#4184 RE: Hezekia #4181

Why don't you copy/paste the reply that you received here? Maybe that will be enough to calm miketrav69 down.
icon url

MONYMAN3

11/26/19 9:51 AM

#4186 RE: Hezekia #4181

Hezekia,
I for one find your presence and comments to be useful. I hope you continue to post. The more info we get from people in the field, the better imo. Don't let one poster's comments put you off. As you say he doesn't know you. He can have an opinion;everyone has one. For all I know, I may be one of the "moonboys" he refers to, but to me you sound sincere and again I find value in your comments. Thanks for your input.

Rob
icon url

jugs

11/26/19 10:10 AM

#4187 RE: Hezekia #4181

You do yourself a disservice, yielding to a negative reception posited by a single poster. This board would lose a keen mind and individual of significant professional medical work-history were you to depart for calmer waters.

You clearly grasp certain things some of us others here may not find accessible due to a lack of understanding and resultant sensitivity. I implore you to reconsider your thoughts of departure. Speaking for myself, I especially appreciate your display of dignity.

About emails not answered:

A couple of months ago I sent an email to Tim Rooney, the finance man. Shockingly to me, at least, I received a response from him in less than two hours. I posted the transaction history on this board as I was immensely pleased to have heard back so quickly. Apparently others haven't been so fortunate. That has me wondering if the tone of emails sent to Avita are openly fair and unbiased. Prior to retirement, I headed up the Investor Relations department for a traded company. Angry emails were pre-screened and not forwarded to me, but, instead, to someone lower on the totem pole. This is routine in most companies, as I understand it.

Thus, I wonder about the pitch and tone of inquiries, at least some of the time. Also, IR responsibilities can and often will be enormous and we of the retail crowd need to keep in mind that the job of IR is not like turning on a light or bringing mail to an office. Often, responses require prior discussion with corporate attorneys and the company President.

As in most situations in life, things are rarely simple.